Cargando…

Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis

AIM: To examine if liver transplant recipients with high-risk non-alcoholic steatohepatitis (NASH) are at increased risk for pre-transplant portal venous thrombosis. METHODS: Data on all liver transplants in the United States from February 2002 through September 2014 were analyzed. Recipients were s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stine, Jonathan G, Argo, Curtis K, Pelletier, Shawn J, Maluf, Daniel G, Caldwell, Stephen H, Northup, Patrick G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Retrospective Cohort Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295147/ https://www.ncbi.nlm.nih.gov/pubmed/28217250 http://dx.doi.org/10.4254/wjh.v9.i3.139

Ejemplares similares

Spontaneous bacterial peritonitis prevalence in pre-transplant patients and its effect on survival and graft loss post-transplant
por: Shah, Neeral L, et al.
Publicado: (2016)

Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis
por: Stine, Jonathan G., et al.
Publicado: (2018)

Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension
por: Yan, Xuan-Hui, et al.
Publicado: (2022)

Inherited thrombophilia and portal vein thrombosis in cirrhosis: A systematic review and meta‐analysis
por: Ma, Steven D., et al.
Publicado: (2019)

Portosplenomesenteric vein thrombosis in patients with early-stage severe acute pancreatitis
por: Ding, Ling, et al.
Publicado: (2018)

Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus
por: Zhang, Yue, et al.
Publicado: (2019)

Hospital contacts with alcohol problems prior to liver cirrhosis or pancreatitis diagnosis
por: Askgaard, Gro, et al.
Publicado: (2017)

Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort
por: Myc, Lukasz A, et al.
Publicado: (2017)

Non-invasive prediction of non-alcoholic steatohepatitis in Japanese patients with morbid obesity by artificial intelligence using rule extraction technology
por: Uehara, Daisuke, et al.
Publicado: (2018)

Divergent trajectories of lean vs obese non-alcoholic steatohepatitis patients from listing to post-transplant: A retrospective cohort study
por: Qazi-Arisar, Fakhar Ali, et al.
Publicado: (2022)

Standards of liver cirrhosis care in Central Australia
por: Raja, Sreecanth S, et al.
Publicado: (2022)

Establishment of a risk assessment score for deep vein thrombosis after artificial liver support system treatment
por: Ye, Yun, et al.
Publicado: (2021)

Portal vein thrombosis in patients with cirrhosis
por: von Köckritz, Leona, et al.
Publicado: (2017)

Reconstructing the portal vein through a posterior pancreatic tunnel: New choice for portal vein thrombosis during liver transplantation
por: Zhao, Dong, et al.
Publicado: (2022)

Association between alcohol-associated cirrhosis and inpatient complications among COVID-19 patients: A propensity-matched analysis from the United States
por: Inayat, Faisal, et al.
Publicado: (2023)

Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8(th) edition of the American Joint Committee on Cancer staging system
por: Chen, Hong-Yu, et al.
Publicado: (2019)

Transient portal vein thrombosis in liver cirrhosis
por: Qi, Xingshun, et al.
Publicado: (2018)

Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes
por: Carr, B.I., et al.
Publicado: (2021)

Natural history and outcomes of patients with liver cirrhosis complicated by hepatic hydrothorax
por: Romero, Sarah, et al.
Publicado: (2022)

Comparison of simplified and traditional pericardial devascularisation combined with splenectomy for the treatment of portal hypertension
por: Zhang, Ya-Fei, et al.
Publicado: (2018)

Portal Vein Thrombosis in Decompensated Cirrhosis: Rationale for Treatment
por: Senzolo, Marco, et al.
Publicado: (2019)

Controversies in the Management of Portal Vein Thrombosis in Liver Cirrhosis
por: Mancuso, Andrea
Publicado: (2020)

Acute portal vein thrombosis with COVID-19 and cirrhosis
por: Miyazato, Yusuke, et al.
Publicado: (2021)

Portal vein thrombosis in cirrhosis: A literature review
por: Prakash, Swathi, et al.
Publicado: (2023)

Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis
por: De Roza, Marianne Anastasia, et al.
Publicado: (2019)

Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis
por: Surana, Pallavi, et al.
Publicado: (2021)

Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Antibody and complement levels in patients with hypersplenism associated with cirrhotic portal hypertension and therapeutic principles
por: Zhang, Kun, et al.
Publicado: (2022)

Machine learning predicts portal vein thrombosis after splenectomy in patients with portal hypertension: Comparative analysis of three practical models
por: Li, Jian, et al.
Publicado: (2022)

Nonselective beta-blocker use is associated with increased hepatic encephalopathy-related readmissions in cirrhosis
por: Fallahzadeh, Mohammad Amin, et al.
Publicado: (2022)

Anticoagulation and Transjugular Intrahepatic Portosystemic Shunting for Treatment of Portal Vein Thrombosis in Cirrhosis: A Systematic Review and Meta-Analysis
por: Davis, Jessica P. E., et al.
Publicado: (2019)

Clostridioides difficile infection in liver cirrhosis patients: A population-based study in United States
por: Sahra, Syeda, et al.
Publicado: (2021)

Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis
por: Dong, Gang, et al.
Publicado: (2021)

Efficacy and safety of autologous stem cell transplantation for decompensated liver cirrhosis: A retrospective cohort study
por: Wang, Ming-Fang, et al.
Publicado: (2018)

Favorable clinical outcome of nonalcoholic liver cirrhosis patients with coronary artery disease: A population-based study
por: Tsai, Ming-Chang, et al.
Publicado: (2018)

Effect of liver cirrhosis on long-term outcomes after acute respiratory failure: A population-based study
por: Lai, Chih-Cheng, et al.
Publicado: (2017)

Nomogram for predicting transmural bowel infarction in patients with acute superior mesenteric venous thrombosis
por: Jiang, Meng, et al.
Publicado: (2020)

Agitation thrombolysis combined with catheter-directed thrombolysis for the treatment of non-cirrhotic acute portal vein thrombosis
por: Wang, Chao-Yang, et al.
Publicado: (2018)

Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis
por: Li, Shao-Hua, et al.
Publicado: (2017)

Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study
por: Afify, Shimaa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9hroumv59togvj7guo4lu7v1li